What the $56.5 million Matrix and HealthFair settlement means for your risk adjustment program

The Department of Justice put a dollar figure on invalid diagnoses, and the number reaches straight into your vendor relationships. On June 3, 2026, Community Care Health Network (operating as Matrix Medical Network), DPN USA (operating as HealthFair), and HealthFair founder Shahriah “James” Ekbatani agreed to pay a combined $56.5 million to resolve False Claims Act allegations. The government said they caused Medicare Advantage (MA) organizations to submit false or invalid diagnosis codes for risk adjustment. If your plan buys in-home assessments or health risk assessments, this case maps almost exactly onto your own exposure.

What the settlement covers

Matrix will pay $36.5 million. HealthFair, acquired by Matrix in 2018, will pay $5 million. Ekbatani will pay $15 million. Two whistleblowers brought the underlying lawsuits under the False Claims Act: a former Matrix employee and HealthFair’s former chief medical officer. They will receive $7.3 million and $3.6 million.

The allegations are specific. From 2014 to 2019, Matrix performed in-home assessments and reported chronic conditions to MA plans, including proliferative diabetic retinopathy, drug-induced polyneuropathy, rheumatoid polyneuropathy, atrial fibrillation, rheumatoid arthritis, chronic obstructive pulmonary disease, and simple chronic bronchitis. The DOJ said these diagnoses lacked sufficient supporting information, broke CMS coding and reporting guidelines, and frequently appeared nowhere else in the patient’s record across a five-year window. No other provider who saw the beneficiary reported the condition.

HealthFair’s pattern looks familiar. From 2015 to 2017, providers on its mobile health buses diagnosed conditions such as HIV/AIDS, metastatic cancer, and Myasthenia Gravis without documentation confirming the condition existed. They coded morbid obesity, rheumatoid arthritis, drug dependence, major depressive disorder, and COPD based only on patient attestation, claims history, or medication lists. They reported congestive heart failure and arrhythmia even when EKG and echocardiogram results contradicted the call, and diagnosed thrombophilia based only on a separate atrial fibrillation diagnosis.

Why this lands now

The settlement arrives as federal enforcement sharpens. The administration launched a Task Force to Eliminate Fraud and a National Fraud Enforcement Division this year, and the DOJ named both as partners in the resolution. HHS-OIG framed the conduct as putting profit ahead of patients. Risk adjustment sits at the center of the message, and home visits and health risk assessments have drawn rising attention from auditors and prosecutors.

The case also shows how liability travels. Matrix and HealthFair are not health plans. They are downstream vendors, and the DOJ pursued them directly, along with a named individual.

Company statement from Matrix Medical Network

“Matrix is the largest independent provider of in-home health assessment and care services in the U.S., and our network of board-certified practitioners has served patients for over 25 years. Our independence from insurers and flat-fee business model mean our sole incentive is providing exceptional in-home health assessment and care services that identify unmet needs and improve health outcomes for patients, all in compliance with the laws and regulations governing our industry. These settlements relate to historical documentation practices regarding a discrete set of clinical diagnoses for Medicare Advantage patients that occurred under prior leadership between 2014 and 2019 and alleged conduct at a now-shuttered subsidiary that predated our 2018 acquisition. Since then, we have made meaningful investments in our compliance program and clinical documentation processes to ensure we meet or exceed all CMS and HHS-OIG standards and guidance. We are pleased to move beyond these matters and direct our full attention to providing high-quality patient care.”
- Spokesperson from Matrix Medical Network

Questions worth raising with your team

  • Which conditions in your risk adjustment data depend on a single home visit?
  • Do your vendors submit diagnoses your own providers never confirm?
  • When did you last audit assessment data against the medical record and against CMS guidelines?
  • Who owns the correction when a vendor code fails review?
  • Do your teams have QA/QC programs to review new and unique codes reported for the first time from in-home health assessments?
  • Do your contracts with vendors require downstream certifications from the vendor regarding the accuracy and truthfulness of the diagnoses submitted, as well as compliance with relevant CMS coding and documentation requirements?

Where you can find answers to these questions

RISE West takes these questions head-on. The Extended Insight Session, “RA Litigation Today: What Lawyers Say About Risk, Enforcement, and Exposure,” brings leading attorneys Ari Yampolsky of Whistleblower Partners LLP and Brian Boynton of WilmerHale to the stage. They break down recent FCA cases, DOJ priorities, and OIG audit trends, point to the fact patterns courts and regulators treat as credible violations, and weigh where enforcement heads next, including possible expansion into Star Ratings. Bring your real-world compliance questions to the live Q and A and leave with a plan to act on them. Explore RISE West and register.

Source: U.S. Department of Justice, Matrix, HealthFair, and HealthFair Founder Agree to Pay $56.5M to Resolve False Claims Act Allegations (June 3, 2026).